Education
About Us
Working with TipRanks
Follow Us
Inmune Bio (INMB)
:INMB
Inkmune
Cancer, Metastatic Castration-Resistant Prostate Cancer, Mcrpc
Phase I/II
Active Not Recruiting
Study of INKmune in Patients With mCRPC (CaRe Prostate)
Aug 07, 2023
―
Xpro1595
Alzheimer Disease, Dementia, Neurodegenerative Diseases, Mild Cognitive Impairment, Brain Diseases, Central Nervous System Diseases, Tauopathies, Nervous System Diseases, Neurocognitive Disorders, Mental Disorders
Phase II
Completed
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
Mar 07, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Inmune Bio (INMB) have in its pipeline
INMB is currently developing the following drugs: Inkmune, Xpro1595. These drug candidates are in various stages of clinical development as the company works toward FDA approval.